Asafoetida Powder (Shakti Group) - Salmonella contamination (2016)
Class I: A situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death
Class I recall indicates potential for serious health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
1) COMPOUNDED ASAFOETIDA POWDER L.G.¿, NET WT. 50g (1.75OZ.), MANUFACTURED BY: LALJEE GODHOO & CO. 213, Samuel Street, Mumbai - 400 003, (INDIA) MANUFACTURED AT: LALJEE GODHOO & CO. Plot No. 53/4, Road 7/15, M.I.D.C.,Andheri (E). Mumbai - 400 093. (INDIA) Lot No., Pkd & Best Before See Bottom LOT NO. 2323" 2) COMPOUNDED ASAFOETIDA POWDER L.G¿, NET WT. 100g (3.5OZ.), MANUFACTURED BY: LALJEE GODHOO & CO. 213, Samuel Street, Mumbai - 400 003, (INDIA) MANUFACTURED AT: LALJEE GODHOO & CO. Plot N
Brand
SHAKTI GROUP USA LLC
Lot Codes / Batch Numbers
Lot 2323
Products Sold
Lot 2323
SHAKTI GROUP USA LLC is recalling 1) COMPOUNDED ASAFOETIDA POWDER L.G.¿, NET WT. 50g (1.75OZ.), MANUFACTURED BY: LALJEE GODHOO & CO. 2 due to L.G. compounded Asafoetida powder has the potential to be contaminated with Salmonella.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
L.G. compounded Asafoetida powder has the potential to be contaminated with Salmonella.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
NH, NJ, OH, PA, VA
Page updated: Jan 6, 2026